Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2022-05-05 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings
2022-05-05 English
General updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2022. It includes a certificate from the Registrar & Share Transfer Agent confirming compliance. The document is short (1397 characters) and serves as a regulatory compliance notification rather than a financial report or detailed filing. It does not contain financial statements or detailed analysis, nor does it announce voting results, management changes, or capital activities. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents.
2022-04-15 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4), which pertains to annual declarations of shareholding or promoter holdings. The content lists names of promoters and promoter groups with respect to a financial year end date. This type of filing is typically a Major Shareholding Notification, as it reports on significant share ownership levels or promoter holdings. The document is short and does not contain financial statements or management discussion, so it is not an annual report or interim report. It is not an announcement of voting results or a regulatory filing of another type. Therefore, the best fit is Major Shareholding Notification (MRQ).
2022-04-06 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 85% confidence The document contains a schedule or list of meetings with analysts and institutional investors, including dates, names, venues, and types of meetings. The presence of terms like 'Conference Call' and 'One-on-One' meetings suggests this is related to earnings or investor calls. There is no actual financial data or detailed transcript text, but the context strongly indicates this is a transcript or record of company conference calls. Given the content and format, the document is best classified as a Call Transcript (CT). The document length is short but contains meeting details typical of call transcripts rather than just an announcement or invitation.
2022-03-28 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 90% confidence The document contains a schedule of meetings with analysts and institutional investors, including dates, names, venues, and types of meetings such as conference calls and one-on-one calls. There is no detailed financial data, report content, or regulatory filing information. The document is very short (796 characters) and appears to be an announcement or schedule related to investor interactions rather than a full report or transcript. It does not fit into categories like Annual Report, Earnings Release, or Call Transcript. Given the nature and length, it is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2022-03-21 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Capital/Financing Update Classification · 95% confidence The document is a notification addressed to stock exchanges about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about upcoming investor meetings and calls, with no financial data, report, or results presented. The document is short (1894 characters) and serves as an announcement of scheduled meetings rather than a report or transcript. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to investor relations and scheduled meetings with analysts and institutional investors.
2022-03-14 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.